세계의 바이오 소재 시장 (~2029년) : 종류별 (금속 (금, 마그네슘), 세라믹 (산화 알루미늄, 탄소), 폴리머 (폴리에틸렌, 폴리에스테르), 천연 (히알루론산, 콜라겐, 젤라틴)), 용도별 (성형 외과, 치과, CVD, 안과)

■ 영문 제목 : Biomaterials Market by Type (Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)), Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2029

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 BT1556-24 입니다.■ 상품코드 : BT1556-24
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2024년 3월
■ 페이지수 : 664
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : Email (주문후 24시간내 납품)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 바이오
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD4,950 ⇒환산￦6,682,500견적의뢰/주문/질문
Multi User (Five User)USD6,650 ⇒환산￦8,977,500견적의뢰/주문/질문
Corporate LicenseUSD8,150 ⇒환산￦11,002,500견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
"세계의 바이오 소재 시장은 2024년 452억 달러에서 2029년 642억 달러에 달할 것으로 예상되며, 2024~2029년 예측 기간 동안 연평균 7.3%의 성장률을 기록할 것으로 예상됩니다." 지속 가능하고 생분해성 소재에 대한 인식이 높아지면서 향후 몇 년 동안 시장을 견인할 것으로 예상됩니다. 또한, 전 세계적으로 만성질환의 증가와 고령화가 의료용 임플란트 수요를 견인하고 있어 시장 성장에 유리하게 작용할 것으로 예상됩니다. 그러나 생체 재료와 관련된 생체적합성 문제가 시장을 제한할 것으로 예상됩니다.

"금속 생체 재료 부문이 지배적인 점유율을 차지할 것으로 예상됩니다."
유형별로 글로벌 바이오 소재 시장은 고분자(폴리메틸메타크릴레이트, 폴리에틸렌, 폴리에스테르, 폴리염화비닐, 실리콘 고무, 나일론, 폴리에테르 에테르 케톤, 기타 고분자 바이오 소재), 금속(스테인리스 스틸, 티타늄, 티타늄 합금, 코발트 크롬, 티타늄 합금), 천연계(히알루론산, 콜라겐, 섬유소, 셀룰로오스, 키틴, 알긴산, 젤라틴, 키토산, 실크, 기타 천연계 바이오 소재), 세라믹계(인산칼슘, 지르코늄, 산화알루미늄, 산화알루미늄 지르코니아, 산화알루미늄, 황산칼슘, 탄소, 유리)로 분류됩니다. 전통적인 금속 기반 바이오 소재의 사용이 시장 확대를 주도할 것으로 예상됩니다.

"2023년 최대 점유율은 정형외과 부문이 차지할 것으로 예상됩니다."
용도별로 바이오 소재 시장은 조직공학(무기 나노입자, 나노소재, 비계), 안과(인공수정체, 인공각막, 콘택트렌즈, 콘택트렌즈, 안구 조직 기능 대체, 기타 안과 제품), 신경/중추신경계, (신경줄기세포 캡슐화 제품, 피질신경보철물, 하이드로겔 비계, 션트 시스템), 심혈관(가이드 와이어, 카테터, 이식형 제세동기, 스텐트, 센서, 인공혈관, 심장판막, 기타 심혈관 제품), 상처치유(내부조직 실란트, 수술용 지혈재, 탈장용 메쉬, 상처 봉합기구, [스테이플, 봉합사], 접착배리어, 피부대체재), 비뇨기(요도 스텐트, 요도 카테터, 기타 비뇨기 제품), 치과(조직재생재료, 치과용 골이식재 및 대체재, 치과용 멤브레인, 치과용 임플란트), 성형외과(세포성 진피 매트릭스, 안면주름치료기, 바이오엔지니어링 피부, 두개안면외과 제품, 연부조직충전재, 말초신경재생 조직 충전제, 말초신경 복구 장치), 기타 용도(비만 수술, 소화기, 약물 전달 시스템)로 분류됩니다. 이는 근골격계 손상, 골다공증, 골관절염과 같은 정형외과 질환의 유병률 증가에 기인합니다.

"APAC 지역은 더 빠른 속도로 성장할 것으로 예상됩니다."
바이오 소재 시장은 북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카로 구분되며, APAC 지역은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 개인 맞춤형 의료에 대한 인식 증가, 기술 발전과 혁신, 만성 질환의 유병률 증가가 이 지역의 시장 성장을 뒷받침하는 이유입니다.

본 보고서를 위해 실시한 1차 인터뷰는 다음과 같이 분류할 수 있습니다.
- 응답자별 : 공급측 80%, 수요측 20%.
- 응답자 직급별(공급측) : 관리자 - 45%, CXO 및 이사 - 30%, 임원 - 25%, 경영진 - 25%.
- 지역별 : 북미 40%, 유럽 25%, 아시아 태평양 20%, 중남미 10%, 중동 및 아프리카 5%.

보고서 수록 기업 목록
• BASF SE (Germany)
• Covestro AG (Germany)
• Celanese Corporation (US)
• Carpenter Technology Corporation (US)
• DSM (Netherlands)
• Corbion NV (Netherlands)
• Evonik Industries AG (Germany)
• Victrex Plc (UK)
• CeramTec GmbH (Germany)
• Mitsubishi Chemical Group Corporation (Japan)
• CoorsTek Inc. (US)
• Berkeley Advanced Biomaterials (US)
• CAM Bioceramics B.V. (Netherlands)
• Zeus Company Inc. (US)
• AMETEK Inc.(US)
• GELITA AG (Germany)
• The RDI Group (Collagen Solutions (US) LLC)
• Biocomposites (England)
• Noble Biomaterials (US)
• Regenity (US)
• Kuraray Co. Ltd. (Japan)
• Solesis (US)
• Institut Straumann AG (Switzerland)
• Foster Corporation (US)
• CDI Products (US)

조사 범위
본 조사 보고서는 바이오 소재 시장의 상세한 현황을 수록하고 있습니다. 유형, 용도, 지역 등 다양한 부문의 시장 규모와 향후 성장 잠재력을 추정하는 것을 목표로 하고 있습니다. 또한 주요 시장 플레이어의 회사 프로필, 최근 동향, 주요 시장 전략과 함께 상세한 경쟁 분석도 수록되어 있습니다.

보고서 구매의 주요 이점
이 보고서는 전체 바이오 소재 시장과 그 하위 부문의 수익에 대한 가장 근접한 추정치를 제공함으로써 시장 리더/신규 진입자에게 도움이 될 것입니다. 또한, 이해관계자들이 경쟁 현황을 더 잘 이해하고, 비즈니스 포지셔닝을 개선하고, 적절한 시장 진입 전략을 수립할 수 있는 통찰력을 얻을 수 있도록 돕습니다. 이 보고서는 이해관계자들이 시장의 흐름을 이해하고 주요 시장 촉진 요인, 저해 요인, 기회 및 도전 과제에 대한 정보를 제공할 수 있도록 돕습니다.

이 보고서는 다음 사항에 대한 통찰력을 제공합니다.
- 주요 촉진 요인(상처 치유 및 성형외과에서 생체 재료에 대한 수요 증가, 다양한 치료 분야에서 생체 재료 사용 확대, 재생의료 및 맞춤의료에 대한 자금 조달 및 투자 증가, 이식형 장치에 대한 수요 증가), 억제 요인(생체적합성 문제), 기회(생체흡수성 바이오 소재에 대한 관심 증가, 신흥국 의료시장 확대, 개인맞춤형 바이오 소재, 스마트 바이오 소재, 나노공학 바이오 소재, 지속 가능한 바이오 소재의 기회 증가), 도전 과제(내구성 및 장기적 성능 문제) 등이 바이오 소재 시장 성장에 영향을 미치고 있습니다.
- 제품 개발/혁신 : 바이오 소재 시장의 신제품 출시에 대한 자세한 인사이트를 제공합니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 이 보고서는 다양한 지역의 바이오 소재 시장을 분석합니다.
- 시장 다각화 : 바이오 소재 시장의 신제품, 미개척 지역, 최근 개발 및 투자에 대한 자세한 정보를 제공합니다.
- 경쟁 평가 : BASF SE(독일), Covestro AG(독일), Celanese Corporation(미국), Carpenter Technology Corporation(미국), DSM(네덜란드), Corbion NV(네덜란드), Evonik Industries AG (독일), Victrex Plc (영국), CeramTec GmbH (독일), Mitsubishi Chemical Group Corporation (일본), CoorsTek Inc. (미국), Berkeley Advanced Biomaterials(미국), CAM Bioceramics B.V.(네덜란드), Zeus Company Inc.(미국), AMETEK Inc.(미국), GELITA AG(독일) 등의 기업 정보를 포함합니다.
■ 보고서 개요

1 서론
2 조사 방법
3 개요
4 프리미엄 인사이트
5 시장 개요
6 세계의 바이오 소재 시장 규모 : 종류별
7 세계의 바이오 소재 시장 규모 : 용도별
8 세계의 바이오 소재 시장 규모 : 지역별
9 경쟁 현황
10 기업 정보
11 부록

■ 보고서 목차

1 INTRODUCTION 89
1.1 STUDY OBJECTIVES 89
1.2 MARKET DEFINITION 89
1.2.1 INCLUSIONS & EXCLUSIONS 89
1.3 MARKET SCOPE 90
1.3.1 MARKETS COVERED 90
1.3.2 YEARS CONSIDERED 91
1.3.3 CURRENCY CONSIDERED 91
1.4 RESEARCH LIMITATIONS 91
1.5 STAKEHOLDERS 92
1.6 SUMMARY OF CHANGES 92
1.7 RECESSION IMPACT 93
2 RESEARCH METHODOLOGY 94
2.1 RESEARCH DATA 94
FIGURE 1 RESEARCH DESIGN 94
2.1.1 SECONDARY DATA 95
2.1.2 PRIMARY DATA 96
FIGURE 2 BIOMATERIALS MARKET: BREAKDOWN OF PRIMARIES 96
2.2 MARKET SIZE ESTIMATION 97
FIGURE 3 BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 97
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 98
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BASF SE: REVENUE SHARE ANALYSIS, 2023 98
2.2.1 INSIGHTS FROM PRIMARIES 100
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 100
2.2.2 SEGMENT ASSESSMENT (BY TYPE AND APPLICATION) 100
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 100
2.3 GROWTH RATE ASSUMPTIONS 101
FIGURE 8 BIOMATERIALS MARKET: CAGR PROJECTIONS, 2024–2029 102
FIGURE 9 BIOMATERIALS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 102
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 103
FIGURE 10 DATA TRIANGULATION METHODOLOGY 103
2.5 STUDY ASSUMPTIONS 104
2.6 RISK ANALYSIS 104
2.7 IMPACT OF ECONOMIC RECESSION ON BIOMATERIALS MARKET 104
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 105
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 105
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 105
3 EXECUTIVE SUMMARY 106
FIGURE 11 BIOMATERIALS MARKET, BY TYPE, 2024 VS 2029 (USD BILLION) 106
FIGURE 12 BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION) 107
FIGURE 13 BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION) 108
FIGURE 14 REGIONAL SNAPSHOT OF BIOMATERIALS MARKET 109
4 PREMIUM INSIGHTS 110
4.1 BIOMATERIALS MARKET OVERVIEW 110
FIGURE 15 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE MARKET 110
4.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY (2023) 111
FIGURE 16 US AND METALLIC BIOMATERIALS COMMANDED LARGEST SHARE IN NORTH AMERICAN BIOMATERIALS MARKET IN 2023 111
4.3 BIOMATERIALS MARKET, BY TYPE 112
FIGURE 17 METALLIC BIOMATERIALS TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 112
4.4 BIOMATERIALS MARKET, BY APPLICATION 113
FIGURE 18 ORTHOPEDIC SEGMENT TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 113
5 MARKET OVERVIEW 114
5.1 INTRODUCTION 114
5.2 MARKET DYNAMICS 114
FIGURE 19 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 114
5.2.1 DRIVERS 115
5.2.1.1 Growing demand for biomaterials in wound healing and plastic surgery 115
5.2.1.2 Growing use of biomaterials in various therapeutic areas 115
5.2.1.3 Rising funding and investments in regenerative and personalized medicine 116
5.2.1.4 Growing demand for implantable devices 116
5.2.2 RESTRAINTS 117
5.2.2.1 Biocompatibility issues 117
5.2.3 OPPORTUNITIES 118
5.2.3.1 Growing interest in bioabsorbable biomaterials 118
5.2.3.2 Expanding healthcare market in emerging economies 118
5.2.3.3 Rising opportunities in personalized, smart, nanoengineered, and sustainable biomaterials 119
5.2.4 CHALLENGES 120
5.2.4.1 Durability and long-term performance issues 120
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 121
FIGURE 20 BIOMATERIALS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 121
5.4 PRICING ANALYSIS 121
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 121
TABLE 4 AVERAGE SELLING PRICE OF BIOMATERIAL PRODUCTS 121
TABLE 5 AVERAGE SELLING TREND OF BIOMATERIAL PRODUCTS, BY REGION 122
5.5 VALUE CHAIN ANALYSIS 123
FIGURE 21 BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS 123
5.6 SUPPLY CHAIN ANALYSIS 124
FIGURE 22 BIOMATERIALS MARKET: SUPPLY CHAIN ANALYSIS 124
TABLE 6 BIOMATERIALS MARKET: SUPPLY CHAIN ANALYSIS 125
5.7 ECOSYSTEM ANALYSIS 126
FIGURE 23 BIOMATERIALS MARKET: ECOSYSTEM/MARKET MAP 126
5.7.1 METALLIC BIOMATERIALS VENDORS 126
TABLE 7 METALLIC BIOMATERIALS VENDORS 126
5.7.2 CERAMIC BIOMATERIALS VENDORS 127
TABLE 8 CERAMIC BIOMATERIALS VENDORS 127
5.7.3 POLYMERIC BIOMATERIALS VENDORS 127
TABLE 9 POLYMERIC BIOMATERIALS VENDORS 127
5.7.4 NATURAL BIOMATERIALS VENDORS 128
TABLE 10 NATURAL BIOMATERIALS VENDORS 128
5.7.5 BIOMATERIALS END USERS 128
TABLE 11 BIOMATERIALS END USERS 129
5.7.6 BIOMATERIALS REGULATORY BODIES 129
TABLE 12 BIOMATERIALS REGULATORY BODIES 129
5.8 TECHNOLOGY ANALYSIS 130
5.9 PATENT ANALYSIS 131
5.9.1 METHODOLOGY 131
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 131
TABLE 13 PATENTS FILED, 2014–2024 131
5.9.3 INNOVATION AND PATENT APPLICATIONS 131
FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 131
5.9.4 TOP APPLICANTS 132
FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024 132
FIGURE 26 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024 132
TABLE 14 TOP 12 PATENT OWNERS IN BIOMATERIALS MARKET, 2014–2024 133
TABLE 15 PATENTS IN BIOMATERIALS MARKET, 2023 133
5.10 TRADE DATA 135
5.10.1 STAINLESS STEEL 135
TABLE 16 IMPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD) 135
TABLE 17 EXPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD) 136
TABLE 18 IMPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS) 136
TABLE 19 EXPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS) 137
5.10.2 SILVER 137
TABLE 20 IMPORT VALUE FOR SILVER, 2018–2022 (USD) 137
TABLE 21 EXPORT VALUE FOR SILVER, 2018–2022 (USD) 138
TABLE 22 IMPORT VOLUME FOR SILVER, 2018–2022 (TONS) 138
TABLE 23 EXPORT VOLUME FOR SILVER, 2018–2022 (TONS) 139
5.10.3 ALUMINUM OXIDE 139
TABLE 24 IMPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD) 139
TABLE 25 EXPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD) 140
TABLE 26 IMPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS) 140
TABLE 27 EXPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS) 141
5.10.4 SILICONE 141
TABLE 28 IMPORT VALUE FOR SILICONE, 2018–2022 (USD) 141
TABLE 29 EXPORT VALUE FOR SILICONE, 2018–2022 (USD) 142
TABLE 30 IMPORT VOLUME FOR SILICONE, 2018–2022 (TONS) 142
TABLE 31 EXPORT VOLUME FOR SILICONE, 2018–2022 (TONS) 143
5.10.5 CELLULOSE 143
TABLE 32 IMPORT VALUE FOR CELLULOSE, 2018–2022 (USD) 143
TABLE 33 EXPORT VALUE FOR CELLULOSE, 2018–2022 (USD) 144
TABLE 34 IMPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS) 144
TABLE 35 EXPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS) 145
5.10.6 GELATIN 145
TABLE 36 IMPORT VALUE FOR GELATIN, 2018–2022 (USD) 145
TABLE 37 EXPORT VALUE FOR GELATIN, 2018–2022 (USD) 146
TABLE 38 IMPORT VOLUME FOR GELATIN, 2018–2022 (TONS) 146
TABLE 39 EXPORT VOLUME FOR GELATIN, 2018–2022 (TONS) 147
5.11 KEY CONFERENCES & EVENTS IN 2024–2025 147
TABLE 40 BIOMATERIALS CONFERENCES IN 2024–2025 147
5.12 REGULATORY LANDSCAPE 153
5.12.1 FDA REGULATIONS ON BIOMATERIALS 153
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 153
TABLE 41 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 153
TABLE 42 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 154
TABLE 43 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 155
TABLE 44 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 156
5.13 PORTER’S FIVE FORCES ANALYSIS 157
TABLE 45 BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS 157
5.13.1 THREAT OF NEW ENTRANTS 157
5.13.2 THREAT OF SUBSTITUTES 158
5.13.3 BARGAINING POWER OF BUYERS 158
5.13.4 BARGAINING POWER OF SUPPLIERS 158
5.13.5 DEGREE OF COMPETITION 158
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 159
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 159
TABLE 46 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 159
5.14.2 BUYING CRITERIA FOR BIOMATERIAL PRODUCTS 159
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 159
TABLE 47 KEY BUYING CRITERIA FOR TOP THREE END USERS 160
6 BIOMATERIALS MARKET, BY TYPE 161
6.1 INTRODUCTION 162
TABLE 48 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 162
TABLE 49 BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 163
6.2 METALLIC BIOMATERIALS 163
TABLE 50 BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 51 BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION) 164
6.2.1 STAINLESS STEEL 165
6.2.1.1 Stainless steel to command largest share in metallic biomaterials segment during forecast period 165
TABLE 52 STAINLESS STEEL MARKET, BY REGION, 2022–2029 (USD MILLION) 165
6.2.2 TITANIUM & TITANIUM ALLOYS 166
6.2.2.1 Growing number of joint replacement procedures to aid segment growth 166
TABLE 53 TITANIUM & TITANIUM ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION) 166
6.2.3 COBALT-CHROME ALLOYS 167
6.2.3.1 Low cost and high corrosion resistance to propel segment growth 167
TABLE 54 COBALT-CHROME ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION) 167
6.2.4 SILVER 167
6.2.4.1 Toxic properties and low aesthetic appeal to limit segment growth 167
TABLE 55 SILVER MARKET, BY REGION, 2022–2029 (USD MILLION) 168
6.2.5 GOLD 168
6.2.5.1 Increasing use in drug delivery, gene therapy, diagnosis, and tissue regeneration to drive segment 168
TABLE 56 GOLD MARKET, BY REGION, 2022–2029 (USD MILLION) 169
6.2.6 MAGNESIUM 169
6.2.6.1 High biocompatibility and low weight to support market growth 169
TABLE 57 MAGNESIUM MARKET, BY REGION, 2022–2029 (USD MILLION) 170
6.2.7 OTHER METALLIC BIOMATERIALS 170
TABLE 58 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION) 171
6.3 POLYMERIC BIOMATERIALS 171
TABLE 59 APPLICATIONS OF SYNTHETIC POLYMERS 172
TABLE 60 BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 61 BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION) 173
6.3.1 POLYMETHYLMETHACRYLATE 173
6.3.1.1 Better biocompatibility and improved safety to drive segment 173
TABLE 62 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2022–2029 (USD MILLION) 174
6.3.2 POLYETHYLENE 174
6.3.2.1 Better wear and tear resistance to boost segment growth 174
TABLE 63 POLYETHYLENE MARKET, BY REGION, 2022–2029 (USD MILLION) 175
6.3.3 POLYESTER 175
6.3.3.1 Better biodegradability and biocompatibility to propel segment growth 175
TABLE 64 POLYESTER MARKET, BY REGION, 2022–2029 (USD MILLION) 176
6.3.4 POLYVINYLCHLORIDE 176
6.3.4.1 Affordability, high tensile strength, and ease of processing to drive segment growth 176
TABLE 65 POLYVINYLCHLORIDE MARKET, BY REGION, 2022–2029 (USD MILLION) 176
6.3.5 SILICONE RUBBER 177
6.3.5.1 Non-reactivity, stability, and better resistance to extreme environments and temperatures to aid segment growth 177
TABLE 66 SILICONE RUBBER MARKET, BY REGION, 2022–2029 (USD MILLION) 177
6.3.6 NYLON 177
6.3.6.1 Increased use in biological applications and gastrointestinal surgeries to aid segment growth 177
TABLE 67 NYLON MARKET, BY REGION, 2022–2029 (USD MILLION) 178
6.3.7 POLYETHERETHERKETONE 178
6.3.7.1 High resistance to thermal degradation and aqueous environments to support segment growth 178
TABLE 68 POLYETHERETHERKETONE MARKET, BY REGION, 2022–2029 (USD MILLION) 178
6.3.8 OTHER POLYMERIC BIOMATERIALS 179
TABLE 69 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION) 179
6.4 CERAMIC BIOMATERIALS 179
TABLE 70 BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 71 BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION) 180
6.4.1 CALCIUM PHOSPHATE 181
6.4.1.1 Better affinity to human body and higher bioresorbability to drive segment 181
TABLE 72 CALCIUM PHOSPHATE MARKET, BY REGION, 2022–2029 (USD MILLION) 181
6.4.2 ZIRCONIA 181
6.4.2.1 Bio-inertness and low wear rate to aid market growth 181
TABLE 73 ZIRCONIA MARKET, BY REGION, 2022–2029 (USD MILLION) 182
6.4.3 ALUMINUM OXIDE 182
6.4.3.1 Increasing use in hip replacements and dental implants to drive segment 182
TABLE 74 ALUMINUM OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION) 183
6.4.4 CALCIUM SULFATE 183
6.4.4.1 Increased popularity and adoption of tissue regeneration products to limit segment growth 183
TABLE 75 CALCIUM SULFATE MARKET, BY REGION, 2022–2029 (USD MILLION) 184
6.4.5 CARBON 184
6.4.5.1 Increasing use in regenerative medicine and cancer treatment to drive segment 184
TABLE 76 CARBON MARKET, BY REGION, 2022–2029 (USD MILLION) 185
6.4.6 GLASS 185
6.4.6.1 Rising number of orthopedic and dental procedures to boost segment growth 185
TABLE 77 GLASS MARKET, BY REGION, 2022–2029 (USD MILLION) 186
6.5 NATURAL BIOMATERIALS 186
TABLE 78 APPLICATIONS OF NATURAL BIOMATERIALS 186
TABLE 79 BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 80 BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION) 188
6.5.1 HYALURONIC ACID 188
6.5.1.1 Rising prevalence of osteoarthritis among geriatric population to drive segment 188
TABLE 81 HYALURONIC ACID MARKET, BY REGION, 2022–2029 (USD MILLION) 189
6.5.2 COLLAGEN 189
6.5.2.1 Biocompatibility, biodegradability, accessibility, and efficient production processes to drive market 189
TABLE 82 COLLAGEN MARKET, BY REGION, 2022–2029 (USD MILLION) 190
6.5.3 FIBRIN 190
6.5.3.1 High utilization in wound healing and blood clotting to aid market growth 190
TABLE 83 FIBRIN MARKET, BY REGION, 2022–2029 (USD MILLION) 191
6.5.4 CELLULOSE 191
6.5.4.1 Better biodegradability, water-retention capability, and renewability to propel market growth 191
TABLE 84 CELLULOSE MARKET, BY REGION, 2022–2029 (USD MILLION) 192
6.5.5 CHITIN 192
6.5.5.1 Increased use in biomedical sector for wound dressings, drug delivery, and bone repair to drive market 192
TABLE 85 CHITIN MARKET, BY REGION, 2022–2029 (USD MILLION) 193
6.5.6 ALGINATES 193
6.5.6.1 Increased use in gastric reflux treatment to propel market growth 193
TABLE 86 ALGINATES MARKET, BY REGION, 2022–2029 (USD MILLION) 194
6.5.7 GELATIN 194
6.5.7.1 Cost-effectiveness and easy manufacturing process to drive segment growth 194
TABLE 87 GELATIN MARKET, BY REGION, 2022–2029 (USD MILLION) 195
6.5.8 CHITOSAN 195
6.5.8.1 Non-toxicity, antimicrobial attributes, and functional versatility to aid market growth 195
TABLE 88 CHITOSAN MARKET, BY REGION, 2022–2029 (USD MILLION) 196
6.5.9 SILK 196
6.5.9.1 Flexibility, glossiness, and adhesive abilities to boost market growth 196
TABLE 89 SILK MARKET, BY REGION, 2022–2029 (USD MILLION) 197
6.5.10 OTHER NATURAL BIOMATERIALS 197
TABLE 90 OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION) 198
7 BIOMATERIALS MARKET, BY APPLICATION 199
7.1 INTRODUCTION 200
TABLE 91 BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 200
7.2 ORTHOPEDIC 200
TABLE 92 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 93 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 201
7.2.1 JOINT REPLACEMENT 202
TABLE 94 BIOMATERIALS MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 95 BIOMATERIALS MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 203
7.2.1.1 Knee replacement 203
7.2.1.1.1 Growing number of knee replacement procedures to drive market growth 203
TABLE 96 BIOMATERIALS MARKET FOR KNEE REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 204
7.2.1.2 Hip replacement 204
7.2.1.2.1 Large number of procedures performed to support market growth 204
TABLE 97 BIOMATERIALS MARKET FOR HIP REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 205
7.2.1.3 Shoulder replacement 205
7.2.1.3.1 Extensive use of biomaterials in shoulder replacement procedures to boost market 205
TABLE 98 BIOMATERIALS MARKET FOR SHOULDER REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 206
7.2.1.4 Other joint replacement procedures 206
TABLE 99 BIOMATERIALS MARKET FOR OTHER JOINT REPLACEMENT PROCEDURES, BY REGION, 2022–2029 (USD MILLION) 207
7.2.2 BIORESORBABLE TISSUE FIXATION 207
TABLE 100 BIOMATERIALS MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 208
TABLE 101 BIOMATERIALS MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 208
7.2.2.1 Suture anchors 208
7.2.2.1.1 Growing awareness about suture anchor devices to drive market growth 208
TABLE 102 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION, 2022–2029 (USD MILLION) 209
7.2.2.2 Interference screws 209
7.2.2.2.1 Increasing awareness about ACL to contribute to market growth 209
TABLE 103 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION, 2022–2029 (USD MILLION) 210
7.2.2.3 Meniscal repair tacks 210
7.2.2.3.1 Rising sports injuries to drive growth 210
TABLE 104 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2022–2029 (USD MILLION) 210
7.2.2.4 Meshes 211
7.2.2.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants to increase demand for meshes 211
TABLE 105 BIOMATERIALS MARKET FOR MESHES, BY REGION, 2022–2029 (USD MILLION) 211
7.2.3 SPINE SURGERY 211
TABLE 106 BIOMATERIALS MARKET FOR SPINE SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 107 BIOMATERIALS MARKET FOR SPINE SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 212
7.2.3.1 Spinal fusion 212
7.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth 212
TABLE 108 BIOMATERIALS MARKET FOR SPINAL FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 213
7.2.3.2 Minimally invasive fusion 213
7.2.3.2.1 Faster recovery associated with minimally invasive fusion procedures to drive demand 213
TABLE 109 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 214
7.2.3.3 Motion preservation & dynamic stabilization 214
TABLE 110 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 214
TABLE 111 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 215
7.2.3.3.1 Pedicle-based rod systems 215
7.2.3.3.1.1 Rising geriatric population to favor market growth 215
TABLE 112 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 216
7.2.3.3.2 Interspinous spacers 216
7.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to growth 216
TABLE 113 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2022–2029 (USD MILLION) 217
7.2.3.3.3 Artificial discs 217
7.2.3.3.3.1 High biocompatibility to increase use of artificial discs 217
TABLE 114 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION, 2022–2029 (USD MILLION) 218
7.2.4 FRACTURE FIXATION 218
TABLE 115 BIOMATERIALS MARKET FOR FRACTURE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 218
TABLE 116 BIOMATERIALS MARKET FOR FRACTURE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 219
7.2.4.1 Bone plates 219
7.2.4.1.1 Growing use of biomaterials in bone plates to aid growth 219
TABLE 117 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION, 2022–2029 (USD MILLION) 219
7.2.4.2 Screws 220
7.2.4.2.1 Extensive use of screws in orthopedic procedures to boost market 220
TABLE 118 BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2022–2029 (USD MILLION) 220
7.2.4.3 Pins 220
7.2.4.3.1 Growing use of metallic biomaterials in pins to propel growth 220
TABLE 119 BIOMATERIALS MARKET FOR PINS, BY REGION, 2022–2029 (USD MILLION) 221
7.2.4.4 Rods 221
7.2.4.4.1 Growing preference for rods for fracture treatment to fuel growth 221
TABLE 120 BIOMATERIALS MARKET FOR RODS, BY REGION, 2022–2029 (USD MILLION) 221
7.2.4.5 Wires 222
7.2.4.5.1 Extensive use of wires to treat fractures of small bones to aid growth 222
TABLE 121 BIOMATERIALS MARKET FOR WIRES, BY REGION, 2022–2029 (USD MILLION) 222
7.2.5 ORTHOBIOLOGICS 222
7.2.5.1 Rising cases of osteoarthritis to drive growth 222
TABLE 122 BIOMATERIALS MARKET FOR ORTHOBIOLOGICS APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 223
7.3 CARDIOVASCULAR 223
TABLE 123 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 224
TABLE 124 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 224
7.3.1 CATHETERS 225
7.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market 225
TABLE 125 BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2022–2029 (USD MILLION) 225
7.3.2 STENTS 225
7.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents 225
TABLE 126 BIOMATERIALS MARKET FOR STENTS, BY REGION, 2022–2029 (USD MILLION) 226
7.3.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 226
7.3.3.1 Growing geriatric population to increase demand for implantable cardiac defibrillators 226
TABLE 127 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2022–2029 (USD MILLION) 227
7.3.4 PACEMAKERS 227
7.3.4.1 High prevalence of bradycardia to drive demand for pacemakers 227
TABLE 128 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION, 2022–2029 (USD MILLION) 228
7.3.5 SENSORS 228
7.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors 228
TABLE 129 BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2022–2029 (USD MILLION) 228
7.3.6 HEART VALVES 229
7.3.6.1 Growing geriatric population to increase demand for prosthetic valves 229
TABLE 130 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 229
TABLE 131 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION, 2022–2029 (USD MILLION) 230
7.3.7 VASCULAR GRAFTS 230
7.3.7.1 Growing number of research studies to open opportunities for growth 230
TABLE 132 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION, 2022–2029 (USD MILLION) 231
7.3.8 GUIDEWIRES 231
7.3.8.1 Extensive use of guidewires for guiding catheters and placing stents to boost market 231
TABLE 133 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2022–2029 (USD MILLION) 232
7.3.9 OTHER CARDIOVASCULAR PRODUCTS 232
TABLE 134 BIOMATERIALS MARKET FOR OTHER CARDIOVASCULAR PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 233
7.4 OPHTHALMOLOGY 233
TABLE 135 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 233
TABLE 136 BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 234
7.4.1 CONTACT LENSES 234
7.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive market 234
TABLE 137 BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION, 2022–2029 (USD MILLION) 235
7.4.2 INTRAOCULAR LENSES 235
7.4.2.1 Increasing prevalence of cataracts to drive number of cataract surgeries performed 235
TABLE 138 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2022–2029 (USD MILLION) 236
7.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUE 236
7.4.3.1 Increasing funding and research activities for development of bionic eyes to drive market 236
TABLE 139 BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUE, BY REGION, 2022–2029 (USD MILLION) 237
7.4.4 SYNTHETIC CORNEAS 237
7.4.4.1 Growing number of corneal blindness cases worldwide to boost demand for synthetic collagen biomaterials 237
TABLE 140 BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2022–2029 (USD MILLION) 238
7.4.5 OTHER OPHTHALMOLOGY PRODUCTS 238
TABLE 141 BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 238
7.5 DENTAL 239
TABLE 142 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 239
TABLE 143 BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 239
7.5.1 DENTAL IMPLANTS 240
7.5.1.1 Increasing awareness of dental services and improving quality of dental products to boost growth 240
TABLE 144 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN US (2016) 240
TABLE 145 BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2022–2029 (USD MILLION) 241
7.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 241
7.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth 241
TABLE 146 BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION) 242
7.5.3 DENTAL MEMBRANES 242
7.5.3.1 Growing use of dental membranes in oral and periodontal surgery to favor market growth 242
TABLE 147 BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION, 2022–2029 (USD MILLION) 243
7.5.4 TISSUE REGENERATION MATERIALS 243
7.5.4.1 Increasing prevalence of periodontal disease to support growth 243
TABLE 148 BIOMATERIALS MARKET FOR TISSUE REGENERATION MATERIALS, BY REGION, 2022–2029 (USD MILLION) 244
7.6 PLASTIC SURGERY 244
TABLE 149 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 244
TABLE 150 BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 245
7.6.1 SOFT TISSUE FILLERS 245
7.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive demand for soft tissue fillers 245
TABLE 151 BIOMATERIALS MARKET FOR SOFT TISSUE FILLERS, BY REGION, 2022–2029 (USD MILLION) 246
7.6.2 CRANIOFACIAL SURGERY PRODUCTS 246
7.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries 246
TABLE 152 BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 247
7.6.3 FACIAL WRINKLE TREATMENT DEVICES 247
7.6.3.1 Increase in demand for non-surgical treatments to drive market growth 247
TABLE 153 BIOMATERIALS MARKET FOR FACIAL WRINKLE TREATMENT DEVICES, BY REGION, 2022–2029 (USD MILLION) 248
7.6.4 BIOENGINEERED SKINS 248
7.6.4.1 Growing applications of bioengineered skins to boost market 248
TABLE 154 BIOMATERIALS MARKET FOR BIOENGINEERED SKINS, BY REGION, 2022–2029 (USD MILLION) 248
7.6.5 PERIPHERAL NERVE REPAIR DEVICES 249
7.6.5.1 Increasing incidence of trauma cases to support growth 249
TABLE 155 BIOMATERIALS MARKET FOR PERIPHERAL NERVE REPAIR DEVICES, BY REGION, 2022–2029 (USD MILLION) 249
7.6.6 ACELLULAR DERMAL MATRICES 249
7.6.6.1 Ability of ADMs to provide mechanical support to boost demand 249
TABLE 156 BIOMATERIALS MARKET FOR ACELLULAR DERMAL MATRICES, BY REGION, 2022–2029 (USD MILLION) 250
7.7 WOUND HEALING 251
TABLE 157 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 251
TABLE 158 BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 251
7.7.1 WOUND CLOSURE DEVICES 252
TABLE 159 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 160 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2022–2029 (USD MILLION) 252
7.7.1.1 Sutures 253
7.7.1.1.1 Ability to use sutures as advanced biologically active components to drive demand 253
TABLE 161 BIOMATERIALS MARKET FOR WOUND CLOSURE SUTURES, BY REGION, 2022–2029 (USD MILLION) 253
7.7.1.2 Staples 254
7.7.1.2.1 Ability of staples to shorten closure by 70–80% compared to sutures to drive adoption 254
TABLE 162 BIOMATERIALS MARKET FOR WOUND CLOSURE STAPLES, BY REGION, 2022–2029 (USD MILLION) 254
7.7.2 SURGICAL HEMOSTATS 254
7.7.2.1 Ability of surgical hemostats to control bleeding and reduce need for frequent blood transfusions to boost market 254
TABLE 163 BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2022–2029 (USD MILLION) 255
7.7.3 INTERNAL TISSUE SEALANTS 255
7.7.3.1 Ability of internal tissue sealants to control bleeding and hemorrhages to fuel growth 255
TABLE 164 BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2022–2029 (USD MILLION) 255
7.7.4 ADHESION BARRIERS 256
7.7.4.1 Ability of adhesion barriers to promote inflammatory healing process to propel growth 256
TABLE 165 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2022–2029 (USD MILLION) 256
7.7.5 HERNIA MESHES 256
7.7.5.1 Growing use of meshes in hernia repair to boost market 256
TABLE 166 BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION, 2022–2029 (USD MILLION) 257
7.7.6 SKIN SUBSTITUTES 257
7.7.6.1 Diverse range of combinations of skin substitutes to boost demand 257
TABLE 167 BIOMATERIALS MARKET FOR SKIN SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION) 258
7.8 TISSUE ENGINEERING 258
TABLE 168 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 259
TABLE 169 BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 259
7.8.1 SCAFFOLDS 259
7.8.1.1 Rise in organ transplantation procedures to drive market 259
TABLE 170 BIOMATERIALS MARKET FOR SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION) 260
7.8.2 NANOMATERIALS 260
7.8.2.1 Rising research on nanotechnology to drive growth 260
TABLE 171 BIOMATERIALS MARKET FOR NANOMATERIALS, BY REGION, 2022–2029 (USD MILLION) 261
7.8.3 INORGANIC NANOPARTICLES 261
7.8.3.1 Growing demand for nanotechnological medical products to propel market 261
TABLE 172 BIOMATERIALS MARKET FOR INORGANIC NANOPARTICLES, BY REGION, 2022–2029 (USD MILLION) 261
7.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 262
TABLE 173 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 262
TABLE 174 BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 262
7.9.1 SHUNTING SYSTEMS 263
7.9.1.1 Rising cases of hydrocephalus to boost market growth 263
TABLE 175 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 263
7.9.2 CORTICAL NEURAL PROSTHETICS 264
7.9.2.1 Growing use of CNPs to treat paralyzed patients to drive growth 264
TABLE 176 BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2022–2029 (USD MILLION) 264
7.9.3 HYDROGEL SCAFFOLDS 264
7.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds 264
TABLE 177 BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION) 265
7.9.4 NEURAL STEM CELL ENCAPSULATION PRODUCTS 265
7.9.4.1 Lack of substitutes for treatment of neurotrauma to boost market growth 265
TABLE 178 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 266
7.10 URINARY 266
TABLE 179 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION) 267
TABLE 180 BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 267
7.10.1 URINARY CATHETERS 267
7.10.1.1 Development of novel coatings for urinary catheters to boost market 267
TABLE 181 BIOMATERIALS MARKET FOR URINARY CATHETERS, BY REGION, 2022–2029 (USD MILLION) 268
7.10.2 URETHRAL STENTS 268
7.10.2.1 Complications associated with urethral stents to limit market growth 268
TABLE 182 BIOMATERIALS MARKET FOR URETHRAL STENTS, BY REGION, 2022–2029 (USD MILLION) 269
7.10.3 OTHER URINARY PRODUCTS 269
TABLE 183 BIOMATERIALS MARKET FOR OTHER URINARY PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 269

보고서 이미지

※본 조사보고서 [세계의 바이오 소재 시장 (~2029년) : 종류별 (금속 (금, 마그네슘), 세라믹 (산화 알루미늄, 탄소), 폴리머 (폴리에틸렌, 폴리에스테르), 천연 (히알루론산, 콜라겐, 젤라틴)), 용도별 (성형 외과, 치과, CVD, 안과)] (코드 : BT1556-24) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 바이오 소재 시장 (~2029년) : 종류별 (금속 (금, 마그네슘), 세라믹 (산화 알루미늄, 탄소), 폴리머 (폴리에틸렌, 폴리에스테르), 천연 (히알루론산, 콜라겐, 젤라틴)), 용도별 (성형 외과, 치과, CVD, 안과)] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 멸균 서비스 시장 (~2027년)
    MD5671-23 / MarketsandMarkets / 2023년 1월 / 마켓츠앤마켓츠 (MarketsandMarkets)에 따르면 세계의 멸균 서비스 시장 규모가 2022년 45억 달러에서 2027년 59억 달러까지 연평균 5.5% 성장할 것으로 추정하고 있습니다. 본 조사 자료는 세계의 멸균 서비스 시장에 대해 조사 및...“The global sterilization services market is projected to reach USD 5.9 billion by 2027 from an estimated USD 4.5 billion in 2022, at a CAGR of 5.5% during the forecast period.” High prevalence of nosocomial infections, growing number of surgical procedures, the increased adoption of sterilization techniques by the food...
  • 세계의 유방 생검 기기 시장 (~2028년) : 유형별 (바늘, 테이블, 분석 키트, 액체 생검), 절차별 (CNB, FNAB, VAB, 수술), 기술별 (정위 수술, USG, MRI), 용도별 (선별 검사, 치료), 최종 용도별 (병원, 클리닉), 지역별
    MD3615-23 / MarketsandMarkets / 2023년 8월 / "세계의 유방 생검 기기 시장은 2023년 16억 달러에서 2028년 26억 달러에 달할 것으로 예상되며, 2023년부터 2028년까지 연평균 10.0%의 성장률을 기록할 것으로 예측됩니다."유방암 발병률 증가, 유방암 검진 프로그램 시행 증가, 유리한...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 동향 6. 유방 생검 기기 시장 : 유형별 7. 유방 생검 기기 시장 : 시술별 8. 유방 생검 기기 시장 : 기술별 9. 유방 생검 기기 시장 : 용도별 10. 유방 생검 기기 시장 : 최종 용도별 11....
  • 세계의 측방 유동 분석 (LFA) 시장 (~2029년) : 키트, 리더기
    MD6394-24 / MarketsandMarkets / 2024년 2월 / "세계의 측방 유동 분석 (LFA) 시장은 2023년 미화 약 108억 달러로 평가되며, 예측 기간 동안 CAGR 7.6%로 성장하여 2029년까지 미화 약 168억 달러에 달할 것으로 예상됩니다." 측방 유동 분석 (LFA)...1 서론 2 조사 방법 3 개요 4 프리미엄 인사이트 5 시장 개요 6 세계의 측방 유동 분석 (LFA) 시장 규모 : 제품별 7 세계의 측방 유동 분석 (LFA) 시장 규모 : 응용 분야별 8 세계의 측방 유동 분석 (LFA) 키트 및 시약 시장 규모 : 기술별 9 세계의 임상...
  • 세계의 인간 유래 오가노이드 시장 (~2029년) : 제품별 (간, 신장, 췌장 모델 (2D, 3D)), 질환 영역별 (암, 소화기, 신경질환), 용도별 (약물독성, 개별화 의료), 최종 사용자별 (제약기업, 바이오테크 기업, CRO)
    BT 6218 / MarketsandMarkets / 2024년 12월 / ...“인간 유래 오가노이드 시장의 가치는 2024년 추정 11.9억 달러에서 2029년에는 23.3억 달러로 증가할 것이며, 예측 기간 동안 연평균 성장률은 14.4%”인간 유래 오가노이드 연구에 대한 자금 지원의 진전은 연구 능력의 대폭적인 향상과 응용 범위의 확대를 통해 오가노이드 시장의 성장을 직접적으로 촉진할 것입니다. 자금 지원으로 과학자들은 암, 신경 퇴행성 질환, 의약품 개발...
  • 세계의 임상시험 분야 AI 시장 (~2030년) : 기능별 (환자 모집, 시설 최적화, 데이터 관리, 품질, 규제), 단계별 (I, II, III), 질환별 (암, CNS, CVS), 툴별, 최종 사용자별 (제약/바이오테크놀로지, CRO, 병원), 지역별
    HIT 9229 / MarketsandMarkets / 2024년 12월 / ...“임상시험 분야 AI 시장은 2024년 13.5억 달러에서 2030년에는 27.4억 달러에 이를 것으로 예상되며, 2024년부터 2030년까지 연평균 성장률은 12.4%” 유효성 향상, 더 짧은 기간에 환자 모집, 데이터의 정확한 분석에 대한 수요 증가가 임상시험에서 AI 시장을 부추기는 주요 요인이 되고 있습니다. AI를 활용한 솔루션은 임상시험의 다양한 단계에서 기간 단축을 지원하고 예측 모델링과...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!